The effect of pertussis toxin on mediator release from human basophils - PubMed (original) (raw)
. 1987 Jul 1;139(1):161-5.
- PMID: 2438348
The effect of pertussis toxin on mediator release from human basophils
J A Warner et al. J Immunol. 1987.
Abstract
We have found that basophils (n = 9) treated with pertussis toxin (1.0 microgram/ml) fail to respond to a subsequent challenge with either 1.0 microM f-Met peptide (p less than 0.0005) or 0.24 microgram/ml of C5a (p less than 0.0005) although their responses to anti-IgE (0.1 microgram/ml) and A23187 (1.0 microgram/ml) were unaltered. These results were confirmed in purified (average purity = 89 +/- 3%) basophils (n = 4). Leukotriene C4 release was also reduced to 15 +/- 5% of control (p less than 0.005) when pertussis toxin-treated basophils were exposed to 1.0 microM f-Met peptide, although no inhibition was noted when anti-IgE or A23187 were used as the stimuli. The effect of pertussis toxin on basophils appears to be independent of the presence of contaminating mononuclear cells. We found that pertussis toxin inhibited f-Met peptide-induced histamine release regardless of the magnitude of the stimulus (0.01 microM to 1.0 microM f-Met peptide), although anti-IgE-induced release was unaffected over a dose-response curve. The effect of pertussis toxin was found to be both time- and concentration-dependent. The maximum effects were obtained after a 3-hr incubation with 1 microgram/ml of toxin. Lower (0.01 to 0.05 microgram/ml) concentrations of toxin or shorter (30 to 60 min) incubation periods did not significantly (p greater than 0.05) inhibit mediator release.
Similar articles
- Human basophil releasability. III. Genetic control of human basophil releasability.
Marone G, Poto S, Celestino D, Bonini S. Marone G, et al. J Immunol. 1986 Dec 1;137(11):3588-92. J Immunol. 1986. PMID: 2431036 - Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin.
Cirillo R, Triggiani M, Siri L, Ciccarelli A, Pettit GR, Condorelli M, Marone G. Cirillo R, et al. J Immunol. 1990 May 15;144(10):3891-7. J Immunol. 1990. PMID: 1692065 - Histamine release from human basophils in vitro: effects of age of cell donor.
Marone G, Poto S, Columbo M, Quattrin S, Condorelli M. Marone G, et al. Monogr Allergy. 1983;18:139-43. Monogr Allergy. 1983. PMID: 6196620 Review. No abstract available.
Cited by
- Response of FcεRI-bearing leucocytes to omalizumab in chronic spontaneous urticaria.
Alizadeh Aghdam M, Knol EF, van den Elzen M, den Hartog Jager C, van Os-Medendorp H, Knulst AC, Otten HG, Röckmann H. Alizadeh Aghdam M, et al. Clin Exp Allergy. 2020 Mar;50(3):364-371. doi: 10.1111/cea.13566. Epub 2020 Feb 7. Clin Exp Allergy. 2020. PMID: 31925825 Free PMC article. Clinical Trial. - Stability of Syk protein and mRNA in human peripheral blood basophils.
MacGlashan D Jr. MacGlashan D Jr. J Leukoc Biol. 2016 Sep;100(3):535-43. doi: 10.1189/jlb.2A0815-356R. Epub 2016 Mar 15. J Leukoc Biol. 2016. PMID: 26980801 Free PMC article. - Histamine release from basophils in childhood: age dependency and inhibition by pertussis infection and pertussis toxin.
Griese M, Merkel G, Feldmann R, Bergfeld I, Reinhardt D. Griese M, et al. Eur J Pediatr. 1993 Jul;152(7):585-91. doi: 10.1007/BF01954086. Eur J Pediatr. 1993. PMID: 7689056 - Differential coupling of the formyl peptide receptor to adenylate cyclase and phospholipase C by the pertussis toxin-insensitive Gz protein.
Tsu RC, Lai HW, Allen RA, Wong YH. Tsu RC, et al. Biochem J. 1995 Jul 1;309 ( Pt 1)(Pt 1):331-9. doi: 10.1042/bj3090331. Biochem J. 1995. PMID: 7619076 Free PMC article. - Study of the activation mechanism of human GRF(1-29)NH2 on rat mast cell histamine release.
Estévez MD, Alfonso A, Vieytes MR, Louzao MC, Botana LM. Estévez MD, et al. Inflamm Res. 1995 Feb;44(2):87-91. doi: 10.1007/BF01793219. Inflamm Res. 1995. PMID: 7544679
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous